W
WST icon

WealthCollab’s West Pharmaceutical WST Stock Holding History

WealthCollab’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$448 – 1023
2025
Q1 		$448 Hold
2
– – ﹤0.01% 885
2024
Q4 		$656 Hold
2
– – ﹤0.01% 840
2024
Q3 		$601 Hold
2
– – ﹤0.01% 854
2024
Q2 		$659 Hold
2
– – ﹤0.01% 826
2024
Q1 		$792 Hold
2
– – ﹤0.01% 827
2023
Q4 		$705 Buy
+2
New +$708 ﹤0.01% 851

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

WealthCollab's WST Position: Q2 2025 in Review

WealthCollab sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 2 shares — an estimated $448 sold.

WealthCollab first reported a position in WST in Q4 2023 and held it in 6 quarters. The position peaked at $792 in Q1 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • WealthCollab reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • WealthCollab sold 2 West Pharmaceutical shares in Q2 2025, an estimated $448.
  • WealthCollab first reported a position in West Pharmaceutical in Q4 2023 and held it in 6 quarters.
  • WealthCollab's West Pharmaceutical position peaked at $792 in Q1 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on WealthCollab's 13F filing for Q2 2025, filed 15 Aug 2025.